Anna M. Litvak, MD

Anya M. Litvak, MD, joined The Cancer Center at Cooperman Barnabas Medical Center in 2015. Dr. Litvak is a board-certified medical oncologist whose clinical practice is dedicated to the care of patients with breast cancer. She trained at the nation’s top institutions including Baylor College of Medicine, Johns Hopkins Hospital and Memorial Sloan Kettering Cancer Center in Manhattan. Dr. Litvak is committed to bringing exceptional care to women fighting breast cancer.

Dr. Litvak partners with a multidisciplinary team of devoted specialists including nurse navigators, social workers, breast surgeons, breast radiologists, oncology nurses, radiation oncologists, dieticians, physical therapists, lymphedema specialists, geneticists and integrative medicine physicians. As a team, they have one of the largest breast cancer practice in the country.

Dr. Litvak believes in a shared decision making approach and takes pride in educating and empowering her patients to jointly make decisions regarding management plans. Her goal is to optimize chance of cure and prolong survival while respecting and honoring one’s individual needs and wishes.

As a principle investigator of a number of breast cancer trials at the cancer center, Dr. Litvak delivers personalized, state of the art breast cancer care to her patients. She works with academic centers throughout the country to deliver novel, targeted therapies to women with breast cancer. In 2020, Dr. Litvak was selected to be part of the ASCO biomarker committee, a group of leading breast oncologists, who make recommendations on the appropriate use of breast tumor biomarker assays to guide decisions on adjuvant systemic therapy for early stage invasive breast cancer

Visit our Clinical Trials page for a full list of breast cancer clinical trials.